ArticleSAGE open medical case reports2025
Uterine arteries embolization for cesarean scar pregnancy with uterine arteriovenous fistula.
Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine arteriovenous fistula is a vascular disease with a short circuit between the uterine arteries and veins. It is rare in clinical work with unclear incidence. Therefore, we aimed to summarize the disease characteristics of uterine arteriovenous fistula and provide a basis for clinical diagnosis and treatment. Herein, we present a case of cesarean scar pregnancy with uterine arteriovenous fistula in a 35-year-old woman, treated successfully with uterine artery embolization with preservation of her uterus. A preliminary diagnosis of cesarean scar pregnancy was made based on the patient's history and MRI. Bilateral uterine arteriography was performed to diagnose a cesarean scar pregnancy combined with uterine arteriovenous fistula bleeding. Hysteroscopic electroresection was performed for the uterine scar. Massive uterine bleeding occurred during the operation. There was still active bleeding after medication and intrauterine compression balloon hemostasis. Urgent bilateral uterine artery embolization was performed. After the operation, leprorelin 3.75 mg was given by intramuscular injection three times, followed by oral contraceptive drospirenone ethinylestradiol tablets, one tablet a day, to prevent recurrence of uterine arteriovenous fistula. After outpatient follow-up every month, the patient was discharged from the hospital for 3 months. Menstruation returned to normal after drug withdrawal, and no abnormal vaginal bleeding symptoms appeared. Uterine arteriovenous fistula should be considered in the clinical treatment of patients with abnormal vaginal bleeding who cannot be diagnosed clearly. Uterine arteriography is the definitive method, and after interventional treatment, drugs can be used to prevent recurrence and close follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.